<VariationArchive RecordType="classified" VariationID="949414" VariationName="NM_003482.4(KMT2D):c.525_535del (p.Cys175fs)" VariationType="Deletion" Accession="VCV000949414" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-05-17" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="926651" VariationID="949414">
      <GeneList>
        <Gene Symbol="KMT2D" FullName="lysine methyltransferase 2D" GeneID="8085" HGNC_ID="HGNC:7133" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="49018978" stop="49060794" display_start="49018978" display_stop="49060794" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="49412757" stop="49449106" display_start="49412757" display_stop="49449106" Strand="-" />
          </Location>
          <OMIM>602113</OMIM>
          <Haploinsufficiency last_evaluated="2020-01-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2D">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-01-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2D">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003482.4(KMT2D):c.525_535del (p.Cys175fs)</Name>
      <CanonicalSPDI>NC_000012.12:49054115:CGAGCCTGGTGC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="49054116" stop="49054126" display_start="49054116" display_stop="49054126" variantLength="11" positionVCF="49054115" referenceAlleleVCF="CCGAGCCTGGTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="49447899" stop="49447909" display_start="49447899" display_stop="49447909" variantLength="11" positionVCF="49447898" referenceAlleleVCF="CCGAGCCTGGTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C175fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.49447900_49447910del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.49447900_49447910del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.49054117_49054127del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.49054117_49054127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027827.1" sequenceAccession="NG_027827" sequenceVersion="1" change="g.6199_6209del">
            <Expression>NG_027827.1:g.6199_6209del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003482.4" sequenceAccession="NM_003482" sequenceVersion="4" change="c.525_535del" MANESelect="true">
            <Expression>NM_003482.4:c.525_535del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003473.3" sequenceAccession="NP_003473" sequenceVersion="3" change="p.Cys175fs">
            <Expression>NP_003473.3:p.Cys175fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1938253851" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003482.4(KMT2D):c.525_535del (p.Cys175fs) AND Kabuki syndrome" Accession="RCV001220871" Version="3">
        <ClassifiedConditionList TraitSetID="21571">
          <ClassifiedCondition DB="MedGen" ID="C0796004">Kabuki syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22126750</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21571" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33104" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kabuki syndrome</ElementValue>
                <XRef ID="MONDO:0016512" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS147920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kabuki make-up syndrome</ElementValue>
                <XRef ID="Kabuki+syndrome/3945" DB="Genetic Alliance" />
                <XRef ID="313426007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Niikawa-Kuroki syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NKS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KMS</ElementValue>
                <XRef Type="MIM" ID="147920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6810" />
                <XRef ID="6810" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Kabuki syndrome (KS) is characterized by typical facial features (long palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; large, prominent, or cupped ears), minor skeletal anomalies, persistence of fetal fingertip pads, mild-to-moderate intellectual disability, and postnatal growth deficiency. Other findings may include: congenital heart defects, genitourinary anomalies, cleft lip and/or palate, gastrointestinal anomalies including anal atresia, ptosis and strabismus, and widely spaced teeth and hypodontia. Functional differences can include: increased susceptibility to infections and autoimmune disorders, seizures, endocrinologic abnormalities (including isolated premature thelarche in females), feeding problems, and hearing loss.</Attribute>
                <XRef ID="NBK62111" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21882399</ID>
                <ID Source="BookShelf">NBK62111</ID>
              </Citation>
              <XRef ID="2322" DB="Orphanet" />
              <XRef ID="C0796004" DB="MedGen" />
              <XRef ID="MONDO:0016512" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS147920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2727786" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6941469|MedGen:C0796004" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001392884" DateUpdated="2022-05-16" DateCreated="2020-07-16" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22126750</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys175Trpfs*41) in the KMT2D gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with KMT2D-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Loss-of-function variants in KMT2D are known to be pathogenic (PMID: 22126750). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2D" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.49447899_49447909del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796004" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2727786" TraitType="Disease" MappingType="XRef" MappingValue="C0796004" MappingRef="MedGen">
        <MedGen CUI="C0796004" Name="Kabuki syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

